Solórzano JL, Menéndez V, Parra E, Solis L, Salazar R, García-Cosío M, Climent F, et al. Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma. Oncoimmunology. 2024. https://doi.org/10.1080/2162402X.2024.2388304.

Menéndez V, Solórzano JL, García-Cosío M, Cereceda L, Díaz E, Estévez M, et al. Mapping the Spatial Dynamics of the CD4+ T Cell Spectrum in Classical Hodgkin Lymphoma. Mod Pathol. 2024 Jun 25;37(9):100551. https://doi.org/10.1016/j.modpat.2024.100551  (Post-print)

Fernández-Miranda I, Pedrosa L, González-Rincón J, Espinet B, de la Cruz Vicente F, Climent F, et al. Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma. Mod Pathol. 2024;37(7):100516. https://doi.org/10.1016/j.modpat.2024.100516

Fernández S, Cereceda L, Díaz E, Figueroa S, Reguera L, Menéndez V, et al. Circulating tumor DNA for monitoring classic Hodgkin lymphoma patients: Correlation with FDG-PET/CT. EJHaem. 2024;5(1):70-5. https://doi.org/10.1002/jha2.826

Suárez EU, Piris M, Rodríguez-Pinilla SM, García JF, López-Lorenzo JL, Cornago-Navascués J, et al. Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage.  Ann Hematol. 2024. p. 1797-9. https://doi.org/10.1007/s00277-024-05647-6

Menéndez V, Solórzano JL, García-Cosío M, Alonso-Alonso R, Rodríguez M, Cereceda L, et al. Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma. Sci Rep. 2024;14(1):710. https://doi.org/10.1038/s41598-024-51376-1

Sánchez-Beato M, Méndez M, Guirado M, Pedrosa L, Sequero S, Yanguas-Casás N, et al. A genetic profiling guideline to support diagnosis and clinical management of lymphomas. Clin Transl Oncol. 2024;26(5):1043-62. https://doi.org/10.1007/s12094-023-03307-1

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Oliveira Araujo IB, Berti E, et al. Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.  Leukemia. 37. England2023. p. 1944-51. https://doi.org/10.1038/s41375-022-01625-x

Fernández S, Díaz E, Rita CG, Estévez M, Montalbán C, García JF. BET inhibitors induce NF-κB and E2F downregulation in Hodgkin and Reed-Sternberg cells. Exp Cell Res. 2023;430(2):113718. https://doi.org/10.1016/j.yexcr.2023.113718

Fernández S, Solórzano JL, Díaz E, Menéndez V, Maestre L, Palacios S, et al. JAK/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells. Blood Adv. 2022. https://doi.org/10.1182/bloodadvances.2021006336

Menéndez V, Solórzano JL, Fernández S, Montalbán C, García JF. The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good. Cancers (Basel). 2022;14(5). https://doi.org/10.3390/cancers14051360

Carreras J, Hiraiwa S, Kikuti YY, Miyaoka M, Tomita S, Ikoma H, et al. Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel. Cancers (Basel). 2021;13(24). https://doi.org/10.3390%2Fcancers13246384

Bonfiglio F, Bruscaggin A, Guidetti F, Terzi di Bergamo L, Faderl M, Spina V, et al. Genetic andphenotypic attributes of splenic marginal zone lymphoma. Blood. 2022;139(5):732-47. https://doi.org/10.1182/blood.2021012386 

Montalbán C, et al; GELTAMO-IPI Project Investigators.. Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm. Br J Haematol. 2018 Aug;182(4):534-541. doi: 10.1111/bjh.15446. 

Franco F, González-Rincón J, Lavernia J, García JF, Martín P, Bellas C, Piris MA, Pedrosa L, Miramón J, Gómez-Codina J, Rodríguez-Abreu D, Machado I, Illueca C, Alfaro J, Provencio M, Sánchez-Beato M. Mutational profile of primary breast diffuse large B-cell lymphoma. Oncotarget. 2017 Oct 24;8(61):102888-102897.

Cantero D, et al. Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing. J Neuropathol Exp Neurol. 2018 Aug 1;77(8):710-716. doi: 10.1093/jnen/nly048. 

González-Barca E, et al; Spanish Lymphoma Group (GELTAMO). Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma. Oncotarget. 2018 Aug 17;9(64):32383-32399. doi: 10.18632/oncotarget.25892. eCollection 2018 Aug 17. Review. 

Menéndez V, Solórzano JL, García-Cosío M, Alonso-Alonso R, Rodríguez M, Cereceda L, Fernández S, Díaz E, Montalbán C, Estévez M, Piris MA, García JF. Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma. Sci Rep. 2024 Jan 6;14(1):710. doi: 10.1038/s41598-024-51376-1. PMID: 38184757

Fernández S, Cereceda L, Díaz E, Figueroa S, Reguera L, Menéndez V, Solórzano JL, Montalbán C, Estévez M, García JF. Circulating tumor DNA for monitoring classic Hodgkin lymphoma patients: Correlation with FDG-PET/CT. EJHaem. 2023 Nov 29;5(1):70-75. doi: 10.1002/jha2.826. Feb. PMID: 38406538

Fernández S, Solórzano JL, Díaz E, Menéndez V, Maestre L, Palacios S, López M, Velázquez AC, Estévez M, Montalban C, Martinez-Ramirez A, Roncador G, García JF. JAK/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells. Blood Adv. 2023 Aug 8;7(15):4135-4147. doi: 10.1182/bloodadvances.2021006336. PMID: 36459489